Contraception: Focus on Vaginal pH Modulation

Uterine Fibroids: Focus on Medical Management

Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability

Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP

New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)

Expanding Choices in Combined Hormonal Contraceptives—The Contraceptive Patch

The Changing Landscape of Contraceptive Trials: Recent Approvals and Future Directions

The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert Dialogue

Advances in Cervical Cancer Screening

A New Era Begins in Contraception: The Vaginal Gel pH Modulator